|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.34 USD | -1.31% |
|
-2.54% | -36.71% |
| 25/11 | Healthcare Stocks Gain Ground -- Healthcare Roundup | DJ |
| 25/11 | Americans waiting for Obamacare subsidies delay or drop health insurance | RE |
| Capitalization | 1.88TCr 1.62TCr 1.52TCr 1.41TCr 2.61TCr 1,69600Cr 2.84TCr 18TCr 6.85TCr 80TCr 7.07TCr 6.92TCr 2,92900Cr | P/E ratio 2025 * |
-3.79x | P/E ratio 2026 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise value | 2.22TCr 1.9TCr 1.78TCr 1.66TCr 3.07TCr 1,99400Cr 3.34TCr 21TCr 8.06TCr 94TCr 8.32TCr 8.14TCr 3,44400Cr | EV / Sales 2025 * |
0.11x | EV / Sales 2026 * | 0.11x |
| Free-Float |
79.74% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Centene Corporation
| 1 day | -1.31% | ||
| 1 week | -2.54% | ||
| Current month | -2.54% | ||
| 1 month | +4.07% | ||
| 3 months | +32.30% | ||
| 6 months | -30.09% | ||
| Current year | -36.71% |
| 1 week | 37.41 |  | 39.34 |
| 1 month | 33.61 | | 39.93 |
| Current year | 25.08 | | 66.81 |
| 1 year | 25.08 | | 66.81 |
| 3 years | 25.08 | | 87.79 |
| 5 years | 25.08 | | 98.53 |
| 10 years | 23.68 | | 98.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah London
CEO | Chief Executive Officer | 44 | 22/03/2022 |
Drew Asher
DFI | Director of Finance/CFO | 56 | 07/05/2021 |
Susan Smith
COO | Chief Operating Officer | 49 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 31/03/2023 | |
Jessica Blume
BRD | Director/Board Member | 70 | 05/02/2018 |
H. Dallas
CHM | Chairman | 66 | 23/02/2022 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.41% | 26 M€ | +11.73% | - |
| 1.31% | 2 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.31% | -2.54% | -33.84% | -55.60% | 1.88TCr | |
| -0.77% | +0.35% | -42.85% | -38.15% | 30TCr | |
| -0.31% | -2.22% | -15.84% | -36.68% | 7.35TCr | |
| -1.11% | -4.27% | -17.72% | -18.92% | 7.09TCr | |
| +1.91% | +4.92% | -8.91% | -52.90% | 3.1TCr | |
| +0.86% | +2.43% | -49.45% | -54.68% | 780.56Cr | |
| +0.77% | +1.77% | +60.25% | +50.97% | 391.18Cr | |
| -0.54% | -8.91% | +60.13% | -29.50% | 207.08Cr | |
| -3.01% | +3.61% | -24.56% | +104.76% | 133.3Cr | |
| -0.17% | -1.03% | -20.30% | - | 39Cr | |
| Average | -0.16% | -0.70% | -9.31% | -14.52% | 5.1TCr | |
| Weighted average by Cap. | +0.48% | -0.48% | -31.88% | -35.96% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 19TCr 17TCr 16TCr 14TCr 27TCr 17,35900Cr 29TCr 1,81700Cr 70TCr 8,19800Cr 72TCr 71TCr 29,97600Cr | 19TCr 17TCr 16TCr 14TCr 27TCr 17,38500Cr 29TCr 1,81900Cr 70TCr 8,21100Cr 73TCr 71TCr 30,02200Cr |
| Net income | -362.19Cr -311.34Cr -291.66Cr -271.85Cr -502.11Cr -33TCr -546.15Cr -3.41TCr -1.32TCr -15TCr -1.36TCr -1.33TCr -56TCr | 89Cr 77Cr 72Cr 67Cr 123.38Cr 8.01TCr 134.2Cr 838.26Cr 323.67Cr 3.78TCr 334.03Cr 326.9Cr 14TCr |
| Net Debt | 331.24Cr 284.73Cr 266.73Cr 248.61Cr 459.2Cr 30TCr 499.48Cr 3.12TCr 1.2TCr 14TCr 1.24TCr 1.22TCr 51TCr | 186.83Cr 160.6Cr 150.45Cr 140.23Cr 259Cr 17TCr 281.72Cr 1.76TCr 679.46Cr 7.94TCr 701.2Cr 686.24Cr 29TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 38.34 $ | -1.31% | 74,70,563 |
| 04/25/04 | 38.85 $ | +0.10% | 47,98,315 |
| 03/25/03 | 38.81 $ | 0.00% | 38,38,195 |
| 02/25/02 | 38.81 $ | +2.43% | 74,06,905 |
| 01/25/01 | 37.89 $ | -3.69% | 64,29,875 |
Delayed Quote Nyse, December 06, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CNC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition